Cancer-specific molecular characterization papers of liver hepatocellular carcinoma (LIHC), lower grade glioma (LGG), and glioblastoma multiforme (GBM) have described mechanisms for their subtype-dependent differences in TERT expression [34,35]. This evidence concerns the gene TERT and central nervous system cancer.